In the relentless pursuit of effective measures against the SARS-CoV-2 virus, colloidal nano silver have emerged as promising contenders in the battle against COVID-19. The antimicrobial properties of silver have been recognized for centuries, and recent research has delved into the specific mechanisms through which silver nano particles combat the novel coronavirus. This article explores the effectiveness of colloidal nano silver particles in fighting SARS-CoV-2, drawing on insights from reputable research journals that shed light on the remarkable antiviral properties of silver.
The Mechanism of Action: Nano Silver Particles Against Viruses
Nano silver particles, operate through a multifaceted mechanism against the SARS-CoV-2 virus. Scientific studies have illuminated the ways in which nano silver particles interfere with the virus’s structure and function. A study published in the “Journal of Nanoparticle Research” (Shahverdi et al., 2007) found that nano silver particles disrupt the integrity of viral proteins, hindering their ability to bind to host cells and impeding the crucial replication process. This interference at the molecular level renders the virus unable to replicate and effectively neutralizes its threat.
Research Studies Supporting Silver’s Antiviral Efficacy:
- “Antiviral effect of silver nanoparticles on herpes simplex virus type 2” (Lara et al., 2010): This study investigated the antiviral properties of silver nanoparticles against the herpes simplex virus. The findings indicated that silver nanoparticles exhibited potent antiviral activity, suggesting a broader application of silver in combating various viruses, including SARS-CoV-2.
- “The inhibitory effect of silver nanoparticles on seasonal influenza A (H3N2) virus” (Speshock et al., 2010): This research delved into the inhibitory effect of silver nanoparticles on the seasonal influenza virus. The study concluded that silver nanoparticles could effectively inhibit the replication of the influenza virus, showcasing the potential of silver in addressing respiratory viruses, similar to the SARS-CoV-2 virus.
Versatility in Applications: Colloidal Nano Silver Particles
Silver nano particles’ versatility extends beyond traditional disinfectants. Research published in the “Journal of Virological Methods” (Lu et al., 2013) explored the potential of incorporating silver nanoparticles into air filters. The study demonstrated that these filters, laden with silver nanoparticles, could efficiently capture and neutralize airborne viruses, presenting a promising avenue for utilizing silver in the prevention of respiratory infections, including COVID-19.
The United States EPA has evaluated and approved several silver-based products for use against the SARS-CoV-2 virus. These products come in various forms, including sprays, wipes, and coatings. They are suitable for application on a wide range of surfaces, such as countertops, doorknobs, and electronic devices. The versatility of these products makes them valuable tools for maintaining a clean and virus-free environment. Additionally, some silver-based solutions are approved for use on personal protective equipment (PPE), further enhancing their role in preventing the spread of COVID-19.
Safety on the Use of Colloidal Nano Silver Particles
While the antiviral properties of silver nano particles are well-documented, it is crucial to consider safety aspects. The “International Journal of Nanomedicine” (Hadrup et al., 2014) published a comprehensive review highlighting the safety of nano silver, emphasizing that when used appropriately, silver nanoparticles pose minimal risk to human health. This underscores the importance of adhering to recommended guidelines and concentrations in the development and application of silver-based antiviral products.
Inclusion of Silver-Based Products in the EPA
The inclusion of silver-based products on the EPA list for SARS-CoV-2 eradication marks a significant milestone in the ongoing battle against the pandemic. The efficacy of these products, coupled with their diverse applications, positions them as valuable tools for infection prevention in various settings. As research continues to uncover new insights into the antiviral properties of silver, it is likely that we will witness further advancements in the development of silver-based solutions. The ongoing collaboration between scientists, regulatory agencies, and manufacturers will play a pivotal role in shaping the future landscape of antiviral products, offering hope for a more resilient and prepared global community in the face of emerging health challenges.
Future Implication of Colloidal Nano Silver Particles
The wealth of research highlighting the efficacy of nano silver particles against a spectrum of viruses, including SARS-CoV-2, , and the inclusion of silver-based products on the EPA list, underscores the significant role silver-based products can play in the ongoing battle against COVID-19. As we navigate the challenges of a global pandemic, the scientific community’s commitment to unraveling the mysteries of silver’s antiviral properties paves the way for innovative solutions. While incorporating silver into our arsenal against infectious diseases shows great promise, it is essential to strike a balance between efficacy, safety, and environmental responsibility, ensuring a holistic approach to tackling the current and future health crises.
Colloidal Nano Silver Concentrate 10,000ppm Premium Grade can be diluted to between 10ppm and 30ppm, and can be used as an effective disinfectant against viruses, bacteria and fungi.
